GE Healthcare to Supply CytoGenix With DNA Production Reagents

GE Healthcare will exclusively provide its DNA production reagents to CytoGenix where the intended application is the manufacture of therapeutic compounds, CytoGenix said today in a statement.

A CytoGenix spokesperson said other labs or companies can license the reagents for purposes other than compound manufacturing.

The companies did not disclose financial terms of the agreement.

Houston, Tex.-based CytoGenix manufactures DNA-based vaccines and therapeutics for infectious diseases, inflammatory disorders, and cancer.

source from GenomeWeb News